EP 2056837 A1 20090513 - AEROSOL FORMULATION FOR THE INHALATION OF BETA-AGONISTS
Title (en)
AEROSOL FORMULATION FOR THE INHALATION OF BETA-AGONISTS
Title (de)
AEROSOLFORMULIERUNG FÜR DIE INHALATION VON BETA-AGONISTEN
Title (fr)
FORMULATION D'AÉROSOL POUR L'INHALATION DE BÊTA-AGONISTES
Publication
Application
Priority
- EP 2007058655 W 20070821
- EP 06119274 A 20060822
- EP 07802747 A 20070821
Abstract (en)
[origin: WO2008023005A1] The present invention relates to a propellant-gas-free aerosol formulation which comprises one or more compounds of the general formula (1) in which the radicals R<SUP>1</SUP>, R<SUP>2</SUP>, R<SUP>3</SUP> and X' can have the meanings given in the claims and in the description for inhalation.
IPC 8 full level
A61K 31/536 (2006.01); A61P 11/00 (2006.01)
CPC (source: EP US)
A61K 31/536 (2013.01 - EP US); A61K 47/14 (2013.01 - EP US); A61K 47/32 (2013.01 - EP US); A61K 47/36 (2013.01 - EP US); A61K 47/38 (2013.01 - EP US); A61P 11/00 (2017.12 - EP); A61P 11/06 (2017.12 - EP); A61P 11/08 (2017.12 - EP)
Citation (search report)
See references of WO 2008023005A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR
Designated extension state (EPC)
AL BA HR MK RS
DOCDB simple family (publication)
WO 2008023005 A1 20080228; AR 062477 A1 20081112; CA 2661442 A1 20080228; EP 2056837 A1 20090513; JP 2010501523 A 20100121; PE 20080425 A1 20080616; TW 200820974 A 20080516; US 2008053430 A1 20080306; UY 30555 A1 20080331
DOCDB simple family (application)
EP 2007058655 W 20070821; AR P070103722 A 20070822; CA 2661442 A 20070821; EP 07802747 A 20070821; JP 2009525053 A 20070821; PE 2007001122 A 20070820; TW 96130913 A 20070821; US 84247207 A 20070821; UY 30555 A 20070821